SAMSUNG PHARM. Co., LTD. acquired 3.1% stake in Enerzent Co., Ltd. for KRW 3 billion.
SAMSUNG PHARM. Co., LTD. (KOSE:A001360) completed the acquisition of 3.1% stake in Enerzent Co., Ltd. (KOSDAQ:A041590)on January 14, 2019.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
789 KRW | +13.69% | -.--% | -21.10% |
04-09 | Flask Co., Ltd. cancelled the transaction announced on March 13, 2024 | CI |
03-28 | Motiva Korea Ltd. cancelled the acquisition of 9.5% stake in Flask Co., Ltd. from B&M Holdings. | CI |
1st Jan change | Capi. | |
---|---|---|
-21.10% | 76.16M | |
-27.72% | 290M | |
-46.20% | 212M | |
-42.90% | 212M | |
+12.05% | 180M | |
-39.22% | 166M | |
+6.91% | 128M | |
+6.73% | 73.77M | |
+15.96% | 62.4M |